Literature DB >> 27797499

Enzymatic Cleavage and Subsequent Facile Intramolecular Transcyclization for in Situ Fluorescence Detection of γ-Glutamyltranspetidase Activities.

Hongjuan Tong1, Yongjun Zheng1, Li Zhou1, Xiangmin Li1, Rui Qian1, Rui Wang1, Jianhong Zhao1, Kaiyan Lou1, Wei Wang1,2.   

Abstract

γ-Glutamyltranspetidase (GGT) is a cell-membrane-bound enzyme which selectively catalyzes cleavage of the γ-glutamyl bond of glutathione (GSH). It has been identified to be overexpressed in a number of malignant tumor cells. Therefore, fluorescent probes for fast and selective detection of GGT activities are greatly needed. However, the majority of currently available GGT fluorescent probes based on direct conjugation of a γ-glutamyl group to a specific fluorophore generally has slow enzymatic kinetics due to bulky fluorophore too close to the enzyme's active site. Moreover, the uncaged fluorophore with a free amine group might undergo oxidation or other enzymatic transformation and resulted in a complicated time-dependent fluorescence response. Herein, we reported design of a novel fluorescent GGT probe NM-GSH (2), which incorporated a fast intramolecular transcyclization cascade for rapid detection of GGT activities after enzymatic cleavage of the γ-glutamyl group. This design strategy allows introduction of bulky 1,8-naphthalimide fluorophore with improved enzymatic kinetics and lowered detection limit. The transcyclized product 4 gives more than 200-fold fluorescence increment. The probe NM-GSH showed both good selectivity and fast detection of GGT activities with the detection limit as low as 0.21 mU/mL. In addition, the fluorescent product 4 contains no free amine group and is more stable for detection. Most importantly, cell imaging studies showed that the transcyclized product 4 was enriched in lysosomes for selectively lighting up GGT-overexpressed ovarian cancer cells (OVCAR5) but not normal cells (HUVEC), indicating NM-GSH's potentials as an imaging agent in cancer diagnosis and treatment.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27797499     DOI: 10.1021/acs.analchem.6b03448

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  6 in total

1.  EGFR-targeting peptide-coupled platinum(IV) complexes.

Authors:  Josef Mayr; Sonja Hager; Bettina Koblmüller; Matthias H M Klose; Katharina Holste; Britta Fischer; Karla Pelivan; Walter Berger; Petra Heffeter; Christian R Kowol; Bernhard K Keppler
Journal:  J Biol Inorg Chem       Date:  2017-04-12       Impact factor: 3.358

2.  Point-of-care Ratiometric Fluorescence Imaging of Tissue for the Diagnosis of Ovarian Cancer.

Authors:  Xiaobo Zhou; Yawei Liu; Qiyu Liu; Luzhe Yan; Meng Xue; Wei Yuan; Mei Shi; Wei Feng; Congjian Xu; Fuyou Li
Journal:  Theranostics       Date:  2019-06-24       Impact factor: 11.556

3.  An anthracenecarboximide-guanidine fluorescent probe for selective detection of glyoxals under weak acidic conditions.

Authors:  Junwei Chen; Yuna Lin; Wanjin Xing; Xingchen Zhang; Huan Xu; Wei Wang; Kaiyan Lou
Journal:  RSC Adv       Date:  2022-03-25       Impact factor: 3.361

4.  A simple two-photon turn-on fluorescent probe for the selective detection of cysteine based on a dual PeT/ICT mechanism.

Authors:  Xiani Chen; Hang Xu; Shengnan Ma; Hongjuan Tong; Kaiyan Lou; Wei Wang
Journal:  RSC Adv       Date:  2018-04-10       Impact factor: 3.361

5.  γ-Glutamyl transpeptidase-activatable near-infrared nanoassembly for tumor fluorescence imaging-guided photothermal therapy.

Authors:  Fangyuan Zhou; Shikui Yang; Chao Zhao; Wangwang Liu; Xufeng Yao; Hui Yu; Xiaolian Sun; Yi Liu
Journal:  Theranostics       Date:  2021-05-13       Impact factor: 11.556

6.  Improving the Stability of Maleimide-Thiol Conjugation for Drug Targeting.

Authors:  Marianne Lahnsteiner; Alexander Kastner; Josef Mayr; Alexander Roller; Bernhard K Keppler; Christian R Kowol
Journal:  Chemistry       Date:  2020-10-27       Impact factor: 5.236

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.